Nucleic Acid Therapeutics Initiative
  • Organisation
  • Science
  • Accelerator
    • Funding Platform
    • Funding Opportunities
    • Portfolio
  • Careers
  • News & Events

Optimization of circular RNA for durable expression in vivo

Posted on February 27, 2026 by Vanessa Tay
← Outbreak Response mRNA Vaccines against H5Nx and H7Nx
Gene Boosting with Novel ASOs for Liver Haploinsufficiency Diseases →
Email
LinkedIn
Nucleic Acid Therapeutics Initiative (NATi)
31 Biopolis Way, Nanos #09-01, Singapore 138669
© 2026 Nucleic Acid Therapeutics Initiative | Privacy Policy | Terms and Conditions
Nucleic Acid Therapeutics Initiative
Join OurMailing List